Literature DB >> 24768627

Impairment of GABA release in the hippocampus at the time of the first spontaneous seizure in the pilocarpine model of temporal lobe epilepsy.

Marie Soukupová1, Anna Binaschi2, Chiara Falcicchia2, Silvia Zucchini3, Paolo Roncon2, Eleonora Palma4, Eros Magri5, Enrico Grandi5, Michele Simonato3.   

Abstract

The alterations in GABA release have not yet been systematically measured along the natural course of temporal lobe epilepsy. In this work, we analyzed GABA extracellular concentrations (using in vivo microdialysis under basal and high K(+)-evoked conditions) and loss of two GABA interneuron populations (parvalbumin and somatostatin neurons) in the ventral hippocampus at different time-points after pilocarpine-induced status epilepticus in the rat, i.e. during development and progression of epilepsy. We found that (i) during the latent period between the epileptogenic insult, status epilepticus, and the first spontaneous seizure, basal GABA outflow was reduced to about one third of control values while the number of parvalbumin-positive cells was reduced by about 50% and that of somatostatin-positive cells by about 25%; nonetheless, high K(+) stimulation increased extracellular GABA in a proportionally greater manner during latency than under control conditions; (ii) at the time of the first spontaneous seizure (i.e., when the diagnosis of epilepsy is made in humans) this increased responsiveness to stimulation disappeared, i.e. there was no longer any compensation for GABA cell loss; (iii) thereafter, this dysfunction remained constant until a late phase of the disease. These data suggest that a GABAergic hyper-responsiveness can compensate for GABA cell loss and protect from occurrence of seizures during latency, whereas impaired extracellular GABA levels can favor the occurrence of spontaneous recurrent seizures and the maintenance of an epileptic state.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GABA release; Parvalbumin; Pilocarpine; Somatostatin; Temporal lobe epilepsy

Mesh:

Substances:

Year:  2014        PMID: 24768627     DOI: 10.1016/j.expneurol.2014.04.014

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  20 in total

1.  Early morphological and functional changes in the GABAergic system of hippocampus in the rat lithium-pilocarpine model of epilepsy.

Authors:  V B Karyakin; D S Vasil'ev; I A Zhuravin; A V Zaitsev; L G Magazanik
Journal:  Dokl Biol Sci       Date:  2017-04-21

Review 2.  Animal models of temporal lobe epilepsy following systemic chemoconvulsant administration.

Authors:  Maxime Lévesque; Massimo Avoli; Christophe Bernard
Journal:  J Neurosci Methods       Date:  2015-03-10       Impact factor: 2.390

Review 3.  Use and Future Prospects of in Vivo Microdialysis for Epilepsy Studies.

Authors:  Alexander G Zestos; Hiram Luna-Munguia; William C Stacey; Robert T Kennedy
Journal:  ACS Chem Neurosci       Date:  2018-07-23       Impact factor: 4.418

4.  Long-Term, Targeted Delivery of GDNF from Encapsulated Cells Is Neuroprotective and Reduces Seizures in the Pilocarpine Model of Epilepsy.

Authors:  Giovanna Paolone; Chiara Falcicchia; Francesca Lovisari; Merab Kokaia; William J Bell; Tracie Fradet; Mario Barbieri; Lars U Wahlberg; Dwaine F Emerich; Michele Simonato
Journal:  J Neurosci       Date:  2019-01-21       Impact factor: 6.167

5.  An update of the classical and novel methods used for measuring fast neurotransmitters during normal and brain altered function.

Authors:  Victor Hugo Cifuentes Castro; Carmen Lucía López Valenzuela; Juan Carlos Salazar Sánchez; Kenia Pardo Peña; Silvia J López Pérez; Jorge Ortega Ibarra; Alberto Morales Villagrán
Journal:  Curr Neuropharmacol       Date:  2014-12       Impact factor: 7.363

6.  Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampus.

Authors:  Germán Sierra-Paredes; Ana I Loureiro; Lyndon C Wright; Germán Sierra-Marcuño; Patrício Soares-da-Silva
Journal:  BMC Neurosci       Date:  2014-12-20       Impact factor: 3.288

7.  Early Gabapentin Treatment during the Latency Period Increases Convulsive Threshold, Reduces Microglial Activation and Macrophage Infiltration in the Lithium-Pilocarpine Model of Epilepsy.

Authors:  Alicia Rossi; Veronica Murta; Jerónimo Auzmendi; Alberto Javier Ramos
Journal:  Pharmaceuticals (Basel)       Date:  2017-11-28

8.  p47Phox/CDK5/DRP1-Mediated Mitochondrial Fission Evokes PV Cell Degeneration in the Rat Dentate Gyrus Following Status Epilepticus.

Authors:  Ji-Eun Kim; Tae-Cheon Kang
Journal:  Front Cell Neurosci       Date:  2017-09-01       Impact factor: 5.505

9.  MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy--comparison with human epileptic samples.

Authors:  Paolo Roncon; Marie Soukupovà; Anna Binaschi; Chiara Falcicchia; Silvia Zucchini; Manuela Ferracin; Sarah R Langley; Enrico Petretto; Michael R Johnson; Gianluca Marucci; Roberto Michelucci; Guido Rubboli; Michele Simonato
Journal:  Sci Rep       Date:  2015-09-18       Impact factor: 4.379

Review 10.  Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students.

Authors:  Katarzyna Lepeta; Mychael V Lourenco; Barbara C Schweitzer; Pamela V Martino Adami; Priyanjalee Banerjee; Silvina Catuara-Solarz; Mario de La Fuente Revenga; Alain Marc Guillem; Mouna Haidar; Omamuyovwi M Ijomone; Bettina Nadorp; Lin Qi; Nirma D Perera; Louise K Refsgaard; Kimberley M Reid; Mariam Sabbar; Arghyadip Sahoo; Natascha Schaefer; Rebecca K Sheean; Anna Suska; Rajkumar Verma; Cinzia Vicidomini; Dean Wright; Xing-Ding Zhang; Constanze Seidenbecher
Journal:  J Neurochem       Date:  2016-09-08       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.